Onchocerciasis Drug Discovery: In Vitro Evaluation of FDA-Approved Drugs against
FDA-approved drugs
O. gutturosa
anthelmintics
drug discovery
motility and MTT inhibition
onchocerciasis
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
31 Jan 2024
31 Jan 2024
Historique:
received:
16
11
2023
revised:
18
01
2024
accepted:
25
01
2024
medline:
24
2
2024
pubmed:
24
2
2024
entrez:
24
2
2024
Statut:
epublish
Résumé
Onchocerciasis treatment and control relies mainly on the use of ivermectin which has high activity against the microfilarial stage of
Identifiants
pubmed: 38399264
pii: pharmaceutics16020210
doi: 10.3390/pharmaceutics16020210
pii:
doi:
Types de publication
Journal Article
Langues
eng